Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 24, 2022Frontiers in ImmunologyOpen Access

Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMasaud ShahHWHyun Goo Woo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shah et al. (2022) studied this question.

synapsesocial.com/papers/6a7c99d6076dbfca02ba5ca9https://doi.org/10.3389/fimmu.2021.830527
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection2021 · 366 citations
  2. 2SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity2020 · 1,072 citations
  3. 3SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion2021 · 1,428 citations